THE CHROMOSOME | Clinical Content Series
Cushing's Syndrome
Back to Case Studies ArchiveCase Study
He was 41 years old and had gained 31 kilograms in less than three years. Not gradually, the way most weight accumulates, but rapidly, almost visibly, in a pattern that confused everyone who knew him. The weight had settled predominantly around his abdomen and the back of his neck. His face had become rounder. His arms and legs, by contrast, had become thinner. He bruised easily. He was weak in a way that made climbing stairs an effort. He had developed stretch marks across his abdomen that were wide and deeply purple, not the pale silver lines of ordinary weight gain but something more dramatic, more sudden, more biological.
Three physicians had told him he was simply gaining weight. One had suggested he was under stress. None of them had looked at his cortisol.
When he arrived at my clinic I identified the clinical picture within the first consultation. This was not stress. This was not dietary excess. This was Cushing's Syndrome, a condition of chronic cortisol excess that produces one of the most distinctive and destructive patterns of weight gain in human endocrinology. The distribution of fat, the muscle wasting in the limbs, the facial changes, the skin fragility, the hypertension I found on examination, every element was consistent.
His 24 hour urinary cortisol was profoundly elevated. His overnight dexamethasone suppression test confirmed what the clinical picture had already told me. His cortisol was not responding to the body's normal regulatory signals. It was running continuously, at high levels, without restraint.
Cushing's Syndrome is rare, but it is far more frequently present and far less frequently diagnosed in Pakistani patients than the medical literature suggests. The FTO gene's influence on hypothalamic pituitary adrenal axis regulation creates a predisposition to cortisol dysregulation in Pakistani patients that makes the recognition of frank Cushing's more difficult against a background of already elevated cortisol patterns. Pakistani physicians trained to look for the textbook presentation frequently miss the subtler cases entirely.
We identified the source. We addressed the cortisol excess through the appropriate clinical pathway. We simultaneously treated the metabolic consequences, the insulin resistance the cortisol had driven, the muscle loss, the visceral fat, the suppressed immune function. It took eighteen months of comprehensive management. But the transformation was complete.
He lost 27 kilograms. His blood pressure normalised. His strength returned. And he told me that for the first time in three years he recognised himself in the mirror.
Cushing's Syndrome does not announce itself loudly in Pakistani patients. You have to know what you are looking for. I have spent a career learning exactly that.
FAQs
Cushing's Syndrome is a condition of chronic cortisol excess, either from overproduction by the adrenal glands, a pituitary tumour driving excess ACTH production, or prolonged use of corticosteroid medications. Cortisol at chronically elevated levels drives fat deposition in a specific and distinctive pattern, accumulating predominantly in the abdomen, face, and posterior neck while simultaneously causing muscle wasting in the limbs. It promotes insulin resistance, elevates blood glucose, suppresses immune function, and impairs bone density. In Pakistani patients this combination of metabolic consequences accelerates with particular severity against the background of FTO associated metabolic vulnerability that many carry from birth.
Ordinary stress elevates cortisol transiently, the levels rise in response to a stressor and fall when it passes. In Cushing's Syndrome cortisol is chronically and pathologically elevated regardless of external circumstances, because the regulatory mechanism that should switch it off has failed. The weight gain pattern is distinctively different from dietary obesity, central and facial fat accumulation with limb muscle wasting, wide purple stretch marks, easy bruising, hypertension, and progressive metabolic deterioration. Pakistani patients with Cushing's are frequently told they are simply stressed and overweight. The distinction between stress and pathological cortisol excess requires specific investigation that most Pakistani clinicians do not routinely pursue.
The FTO gene at Chromosome 16q12.2 influences hypothalamic pituitary adrenal axis regulation, the system that governs cortisol production, release, and suppression. In Pakistani patients, the FTO associated metabolic profile creates a baseline of elevated cortisol reactivity that complicates the identification of frank Cushing's Syndrome against an already disrupted cortisol background. Dr. Zaar's clinical assessment takes this population specific cortisol pattern into account, recognising that the diagnostic thresholds established in Western populations may not translate directly to Pakistani patients carrying this genetic predisposition to heightened adrenal reactivity.
Cortisol raises blood glucose by stimulating the liver to produce glucose and by reducing insulin sensitivity in peripheral tissues. In Cushing's Syndrome this glucose raising effect operates continuously, creating a state of chronic hyperglycaemia that drives the pancreas to produce excess insulin around the clock. Over time this sustained insulin demand produces frank insulin resistance, metabolic syndrome, and frequently type 2 diabetes. The visceral fat accumulated through cortisol excess further amplifies insulin resistance through inflammatory cytokine release, creating a self reinforcing metabolic catastrophe that worsens with every passing month of undiagnosed cortisol excess.
Several factors converge to produce systematic underdiagnosis. The classical textbook presentation, the full moon face, buffalo hump, purple striae, and proximal muscle weakness, is recognisable when present in its complete form but frequently presents incompletely in Pakistani patients. Cortisol testing is not part of standard metabolic panels. Many Pakistani physicians attribute the weight distribution and metabolic features to simple obesity without considering a cortisol driven origin. Additionally, iatrogenic Cushing's, caused by prolonged use of oral or injectable corticosteroids, which are widely and frequently over prescribed in Pakistan, is almost never investigated as a cause of weight gain despite being clinically common. Dr. Zaar investigates cortisol as a routine component of comprehensive obesity assessment.
Iatrogenic Cushing's Syndrome is caused by prolonged exposure to exogenous corticosteroids, medications including prednisolone, dexamethasone, and injectable steroid preparations that are prescribed for conditions ranging from asthma and joint pain to skin conditions and allergic reactions. In Pakistan, corticosteroids are widely available, frequently over prescribed, and sometimes self administered without medical supervision. Prolonged use suppresses the body's own cortisol regulation while simultaneously producing all the metabolic consequences of endogenous Cushing's, central weight gain, insulin resistance, muscle wasting, and bone loss. Dr. Zaar identifies medication history as a critical component of every obesity assessment precisely because iatrogenic cortisol excess is a frequently present and almost never diagnosed cause of weight gain in Pakistani patients.
Chronic cortisol excess suppresses the hypothalamic pituitary gonadal axis, the hormonal cascade that governs reproductive function in both men and women. In women this produces menstrual irregularity, anovulation, and fertility compromise that closely mimics PCOS. In men it suppresses testosterone production, producing hypogonadism with its associated symptoms of low libido, erectile dysfunction, fatigue, and muscle loss. Pakistani patients with undiagnosed Cushing's are frequently treated for the reproductive consequences without the underlying cortisol excess ever being identified. THE CHROMOSOME protocol evaluates the adrenal cortisol axis as part of every comprehensive hormonal assessment, because cortisol sits at the top of the endocrine hierarchy and its dysregulation cascades through every system below it.
The metabolic consequences of Cushing's Syndrome are substantially reversible when cortisol excess is corrected and the secondary hormonal disruptions are treated comprehensively. Insulin resistance improves as cortisol normalises. Visceral fat reduces as the cortisol driven fat storage signal is removed. Muscle mass recovers with targeted nutritional and peptide based support. Blood pressure frequently normalises without medication. However, the speed and completeness of recovery depend entirely on how long the cortisol excess was present before diagnosis and treatment. Every month of undiagnosed Cushing's deepens the metabolic damage and lengthens the recovery. This is why early identification matters, and why Dr. Zaar investigates cortisol in every Pakistani patient presenting with unexplained or rapidly progressive weight gain.